3309

C-MER Medical Holdings Limited Stock Price

SEHK:3309 Community·HK$2.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3309 Share Price Performance

HK$0
-2.00 (-100.00%)
HK$0
-2.00 (-100.00%)
Price HK$0

3309 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

1 Risk
1 Reward

C-MER Medical Holdings Limited Key Details

HK$1.9b

Revenue

HK$1.3b

Cost of Revenue

HK$601.7m

Gross Profit

HK$717.7m

Other Expenses

-HK$116.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.094
31.09%
-5.99%
2.3%
View Full Analysis

About 3309

Founded
2012
Employees
2189
CEO
Xiaoting Li
WebsiteView website
www.cmermedical.com

C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, Mainland China Dental Business, and Mainland China other business. The company provides oncology, medical aesthetics, general practice, ophthalmic, dental, and other medical services; cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services; and medical consumables. It also engages in the sale of vision aid products, such as glasses and lens. The company was formerly known as C-MER Eye Care Holdings Limited and changed its name to C-MER Medical Holdings Limited in June 2024. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Medical Holdings Limited is a subsidiary of C-MER Group Limited.

Recent 3309 News & Updates

Recent updates

No updates